@ARTICLE{10.3389/fmicb.2021.643449, AUTHOR={Chen, Dongmei and He, Jingquan and Li, Jinping and Zou, Qian and Si, Jiawei and Guo, Yatao and Yu, Jiayu and Li, Cheng and Wang, Fang and Chan, Tianlong and Shi, Huijuan}, TITLE={Microbiome and Metabolome Analyses Reveal Novel Interplay Between the Skin Microbiota and Plasma Metabolites in Psoriasis}, JOURNAL={Frontiers in Microbiology}, VOLUME={12}, YEAR={2021}, URL={https://www.frontiersin.org/articles/10.3389/fmicb.2021.643449}, DOI={10.3389/fmicb.2021.643449}, ISSN={1664-302X}, ABSTRACT={Psoriasis is a chronic inflammatory skin disease that affects millions of people worldwide. There is still no effective approach for the clinical treatment of psoriasis. This is largely due to the lack of understanding of the pathological mechanism. Here, we comprehensively characterized the skin microbiome and plasma metabolome alterations of psoriasis patients. We observed that some pathogenic bacteria, including Vibrio, were significantly increased in psoriasis patients. The metabolomics results showed alterations in some metabolic pathways, especially pathways for lipid metabolism. In addition, microbiome-specific metabolites, including bile acids and kynurenine, were significantly changed. Correlation analysis revealed the interplay between the skin microbiota and plasma metabolites, especially between Vibrio and several lipids. Our results provide new evidence for the interplay between the skin microbiome and plasma metabolites, which is dramatically disrupted in psoriasis patients. This study also revealed the mechanism underlying the pathogenesis of psoriasis.} }